CNR1 and systemic sclerosis: Importantly, in this system biological effects of the receptors were also tested by the co-administration of JWH-015, which was found to partially suppress the LPS-induced pro-inflammatory response in a CB1 and CB2 dependent manner [185], inviting the hypothesis that CB1/CB2 activators may exert beneficial anti-inflammatry effects in SSc.